New Horizon Health's high P/S ratio is backed by its robust projected revenue growth, outpacing the rest of the Healthcare sector. Shareholders are optimistic about future revenues, with a low likelihood of a significant share price drop. However, investors should note 2 warning signs.
诺辉健康股票讨论区
未来之星。现在是伏击医疗和消费双轨中估值可能翻倍的时候了。
暂无评论